A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation

Experimental Cell Research

Volumn 318, Issue 3, 2012, Pages 276-287

  Pelz, Sandra ^a   Stock, Peggy ^a   Brückner, Sandra ^a   Christ, Bruno ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cell transplantation; Immunodeficient mouse; Liver; Mesenchymal stem cell; Non alcoholic steatohepatitis; Xenotransplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLINE; COLLAGEN TYPE 1; METHIONINE; SERUM AMYLOID A; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET; ENGRAFTMENT; FATTY LIVER; HEPATITIS; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LIVER FIBROSIS; LIVER INJURY; LIVER LEVEL; MALE; METHIONINE CHOLINE DEFICIENT DIET; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MUS;

EID: 84855860915     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.11.005     Document Type: Article

References (51)

1. Shifflet A., Wu G.Y. Non-alcoholic steatohepatitis: an overview. J. Formos. Med. Assoc. 2009, 108:4-12.
2. Farrell G.C., Teoh N.C., McCuskey R.S. Hepatic microcirculation in fatty liver disease. Anat. Rec. (Hoboken) 2008, 291:684-692.
3. de Alwis N.M., Day C.P. Non-alcoholic fatty liver disease: the mist gradually clears. J. Hepatol. 2008, 48(Suppl. 1):S104-S112.
4. Day C.P. Pathogenesis of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 2002, 16:663-678.
5. Day C.P. Mechanisms of Steatosis: Is steatosis still the first hit?. Progamms and Abstracts EASL special conference - NAFLD/NASH and related metabolic diseases, EASL 2009, 63-64.
6. Sparks J.D., Sparks C.E. Overindulgence and metabolic syndrome: is FoxO1 a missing link?. J. Clin. Invest. 2008, 118:2012-2015.
7. Gyamfi M.A., Damjanov I., French S., Wan Y.J. The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury. Biochem. Pharmacol. 2008, 75:981-995.
8. Parsons C.J., Takashima M., Rippe R.A. Molecular mechanisms of hepatic fibrogenesis. J. Gastroenterol. Hepatol. 2007, 22(Suppl. 1):S79-S84.
9. Friedman S.L., Bansal M.B. Reversal of hepatic fibrosis-fact or fantasy?. Hepatology 2006, 43:S82-S88.
10. Friedman S.L. Liver fibrosis-from bench to bedside. J. Hepatol. 2003, 38(Suppl. 1):S38-S53.
11. Erickson S.K. Nonalcoholic fatty liver disease. J. Lipid Res. 2009, 50:S412-S416. (Suppl).
12. Kakinuma S., Nakauchi H., Watanabe M. Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease. J. Gastroenterol. 2009, 44:167-172.
13. Aurich I., Mueller L.P., Aurich H., Luetzkendorf J., Tisljar K., Dollinger M.M., Schormann W., Walldorf J., Hengstler J.G., Fleig W.E., Christ B. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 2007, 56:405-415.
14. Rinella M.E., Elias M.S., Smolak R.R., Fu T., Borensztajn J., Green R.M. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J. Lipid Res. 2008, 49:1068-1076.
15. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-509.
16. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.
17. Christ B., Brückner S., Stock P. Hepatic transplantation of mesenchymal stem cells in rodent animal models. Methods Mol. Biol. 2011, 698:315-330.
18. Stock P., Bruckner S., Ebensing S., Hempel M., Dollinger M.M., Christ B. The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nat. Protoc. 2010, 5:617-627.
19. Gordon D.A., Jamil H. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim. Biophys. Acta 2000, 1486:72-83.
20. Rinella M.E., Green R.M. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J. Hepatol. 2004, 40:47-51.
21. Lieber C.S. S-adenosyl-l-methionine: its role in the treatment of liver disorders. Am. J. Clin. Nutr. 2002, 76:1183S-1187S.
22. Barak A.J., Beckenhauer H.C., Tuma D.J. Methionine synthase. a possible prime site of the ethanolic lesion in liver. Alcohol 2002, 26:65-67.
23. Vance J.E., Vance D.E. The role of phosphatidylcholine biosynthesis in the secretion of lipoproteins from hepatocytes. Can. J. Biochem. Cell Biol. 1985, 63:870-881.
24. Kulinski A., Vance D.E., Vance J.E. A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein B secretion. J. Biol. Chem. 2004, 279:23916-23924.
25. Blasiole D.A., Davis R.A., Attie A.D. The physiological and molecular regulation of lipoprotein assembly and secretion. Mol. Biosyst. 2007, 3:608-619.
26. Chen Z., Newberry E.P., Norris J.Y., Xie Y., Luo J., Kennedy S.M., Davidson N.O. ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice. J. Lipid Res. 2008, 49:2013-2022.
27. Hussain M.M., Bakillah A. New approaches to target microsomal triglyceride transfer protein. Curr. Opin. Lipidol. 2008, 19:572-578.
28. Shindo N., Fujisawa T., Sugimoto K., Nojima K., Oze-Fukai A., Yoshikawa Y., Wang X., Yasuda O., Ikegami H., Rakugi H. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. J. Hepatol. 2010, 52:903-912.
29. Baron D.N. Clinical enzymology with particular reference to liver disease. Proc. R. Soc. Med. 1963, 56:173-177.
30. Fernandez N.J., Kidney B.A. Alkaline phosphatase: beyond the liver. Vet. Clin. Pathol. 2007, 36:223-233.
31. Scheja L., Heese B., Zitzer H., Michael M.D., Siesky A.M., Pospisil H., Beisiegel U., Seedorf K. Acute-phase serum amyloid A as a marker of insulin resistance in mice. Exp. Diabetes Res. 2008, 2008:230837.
32. Uhlar C.M., Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 1999, 265:501-523.
33. Tomita K., Tamiya G., Ando S., Ohsumi K., Chiyo T., Mizutani A., Kitamura N., Toda K., Kaneko T., Horie Y., Han J.Y., Kato S., Shimoda M., Oike Y., Tomizawa M., Makino S., Ohkura T., Saito H., Kumagai N., Nagata H., Ishii H., Hibi T. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 2006, 55:415-424.
34. Beraza N., Malato Y., Vander Borght S., Liedtke C., Wasmuth H.E., Dreano M., de Vos R., Roskams T., Trautwein C. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut 2008, 57:655-663.
35. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 2000, 275:2247-2250.
36. Kohli R., Feldstein A.E. NASH animal models: are we there yet?. J. Hepatol. 2011, 55:941-943.
37. Carmiel-Haggai M., Cederbaum A.I., Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J. 2005, 19:136-138.
38. Roderfeld M., Weiskirchen R., Wagner S., Berres M.L., Henkel C., Grotzinger J., Gressner A.M., Matern S., Roeb E. Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice. FASEB J. 2006, 20:444-454.
39. Wang X., Willenbring H., Akkari Y., Torimaru Y., Foster M., Al-Dhalimy M., Lagasse E., Finegold M., Olson S., Grompe M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003, 422:897-901.
40. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
41. Brulport M., Schormann W., Bauer A., Hermes M., Elsner C., Hammersen F.J., Beerheide W., Spitkovsky D., Hartig W., Nussler A., Horn L.C., Edelmann J., Pelz-Ackermann O., Petersen J., Kamprad M., von Mach M., Lupp A., Zulewski H., Hengstler J.G. Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers. Hepatology 2007, 46:861-870.
42. Schormann W., Hammersen F.J., Brulport M., Hermes M., Bauer A., Rudolph C., Schug M., Lehmann T., Nussler A., Ungefroren H., Hutchinson J., Fandrich F., Petersen J., Wursthorn K., Burda M.R., Brustle O., Krishnamurthi K., von Mach M., Hengstler J.G. Tracking of human cells in mice. Histochem. Cell Biol. 2008, 130:329-338.
43. Fisher R.A., Strom S.C. Human hepatocyte transplantation: worldwide results. Transplantation 2006, 82:441-449.
44. Nussler A., Konig S., Ott M., Sokal E., Christ B., Thasler W., Brulport M., Gabelein G., Schormann W., Schulze M., Ellis E., Kraemer M., Nocken F., Fleig W., Manns M., Strom S.C., Hengstler J.G. Present status and perspectives of cell-based therapies for liver diseases. J. Hepatol. 2006, 45:144-159.
45. Alison M.R., Islam S., Lim S. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J. Pathol. 2009, 217:282-298.
46. di Bonzo L.V., Ferrero I., Cravanzola C., Mareschi K., Rustichell D., Novo E., Sanavio F., Cannito S., Zamara E., Bertero M., Davit A., Francica S., Novelli F., Colombatto S., Fagioli F., Parola M. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008, 57:223-231.
47. Russo F.P., Alison M.R., Bigger B.W., Amofah E., Florou A., Amin F., Bou-Gharios G., Jeffery R., Iredale J.P., Forbes S.J. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006, 130:1807-1821.
48. Ren H., Zhao Q., Cheng T., Lu S., Chen Z., Meng L., Zhu X., Yang S., Xing W., Xiao Y., Ren Q., Chi Y., Gu D., Yang R., Han Z.C. No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis. Cytotherapy 2010, 12:371-383.
49. Carvalho A.B., Quintanilha L.F., Dias J.V., Paredes B.D., Mannheimer E.G., Carvalho F.G., Asensi K.D., Gutfilen B., Fonseca L.M., Resende C.M., Rezende G.F., Takiya C.M., de Carvalho A.C., Goldenberg R.C. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 2008, 26:1307-1314.
50. Pulavendran S., Vignesh J., Rose C. Differential anti-inflammatory and anti-fibrotic activity of transplanted mesenchymal vs. hematopoietic stem cells in carbon tetrachloride-induced liver injury in mice. Int. Immunopharmacol. 2010, 10:513-519.
51. Chang Y.J., Liu J.W., Lin P.C., Sun L.Y., Peng C.W., Luo G.H., Chen T.M., Lee R.P., Lin S.Z., Harn H.J., Chiou T.W. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci. 2009, 85:517-525.